Skip to content
10-Q

Quarterly Report

TELADOC HEALTH, INC. TDOC

0001477449-25-000049

← back to feed
Filed
May 1, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 24, 2025 175.43M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $1.19B
Cash And Equivalents Q1 2025 · Dec 31, 2024 $1.3B
Current Liabilities Q1 2025 · Mar 31, 2025 $952.42M
Current Liabilities Q1 2025 · Dec 31, 2024 $941.54M
Total Liabilities Q1 2025 · Mar 31, 2025 $2.02B
Total Liabilities Q1 2025 · Dec 31, 2024 $2.03B
Current Assets Q1 2025 · Mar 31, 2025 $1.6B
Current Assets Q1 2025 · Dec 31, 2024 $1.66B
Total Assets Q1 2025 · Mar 31, 2025 $3.44B
Total Assets Q1 2025 · Dec 31, 2024 $3.52B
Shares Diluted Q1 2025 · Mar 31, 2024 167.73M sh
Capex Q1 2025 · Mar 31, 2024 $1.15M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $8.92M
Stockholders Equity Q1 2025 · Mar 31, 2024 $2.29B
Stockholders Equity Q1 2025 · Dec 31, 2023 $2.33B
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.49
Eps Basic Q1 2025 · Mar 31, 2024 −$0.49
Sga Expense Q1 2025 · Mar 31, 2024 $111.7M
Rd Expense Q1 2025 · Mar 31, 2024 $81.39M
Net Income Q1 2025 · Mar 31, 2024 −$81.89M
Operating Income Q1 2025 · Mar 31, 2024 −$87.12M
Revenue Q1 2025 · Mar 31, 2024 $646.13M